PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease

Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease.

Rep. Dan Crenshaw With Urgent Call For Support At House Rules Committee On Psychedelics

In a recent congressional hearing, Rep. Dan Crenshaw again pleaded his case for the advancement of psychedelic use in the mentally ill. The matter at

July 12, 2023

Opinion | Preserve the National Institute of Nursing Research’s Independence

Darcy-Mahoney is a professor, neonatal nurse practitioner, researcher, and educator. Menon is the dean of a college of nursing. Murray is dean emerita, professor, and

November 23, 2024

Biopharma leaders charting a path for the industry’s LGBTQ+ community

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.